Penn Medicine Provider
Gastroenterology
Alice S. Pang, MD
4.8
(158)
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman
Make an appointmentMake an appointment

About me

  • Assistant Professor of Clinical Medicine (Gastroenterology)

Education and training

  • Medical School: University of Chicago
  • Residency: NYU Langone Medical Center
  • Fellowship: Thomas Jefferson University Hospital

What my patients think about me

Average Rating
4.8

158 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
she was patient
April 2025
5.0
5.0
easy to talk too
April 2025
5.0
5.0
she was right on time. was respectful and a good listener. seemed knowledgeable.
March 2025
5.0
5.0
doctor is thorough and prepared for the visit. had good follow up questions and was actively looking for solutions.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Pang is a Penn Medicine physician.

Qualifications and experience

My research

Manski S, Schmoyer C, Pang A, Lieberman J, Gernhardt M, Murugesan N, Leto A, Erwin R, Kavanagh T, Conn M. The Safety of the Re-opening of an Academic Medical Center Outpatient Endoscopy Unit During the COVID-19 Pandemic. , Gastroenterol Res., 15(4): 2022,200-206

Pang A, Halegoua-De Marzio DL, Sass DA, Shah AP, Singh P, Powers T, Ryan M, Fenkel J. (2022). Transplant Evaluation Practices for Kidney Donors and Recipients with History of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States. , Gastroenterology, 162(7): 2022,S-1293

Pang A, Boortalary T, Au C, Henry C, Infantolino A, Tofani C. The Effect of Weekend versus Weekday Admission on Outcomes of Suspected Small Bowel Bleeding. , Gastrointest Endosc, 95 (6): 2022

Hong SJ, Zenger C, Pecoriello J, Pang A, Vallely M, Hudesman DP, Chang S, Axelrad JE. Ustekinumab and Vedolizumab Are Not Associated with Subsequent Cancer in IBD Patients with Prior Malignancy. , Inflamm Bowel Dis., 28(12): 2022,1826-1832

Tapaskar N, Pang A, Werner DA, Sengupta N. Resuming Anticoagulation Following Hospitalization for Gastrointestinal Bleeding Is Associated with Reduced Thromboembolic Events and Improved Mortality: Results from a Systematic Review and Meta-Analysis. , Dig Dis Sci., 66(2): 2021,554-566.

Pang A, Chang S, Axelrad J. Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Vedolizumab or Ustekinumab. , Am J Gastroenterol, 647: 2019,114

Mujumdar S, Goldenberg J, Bieser S, Pang AS, Coben R. Cholestatic Liver Injury in a Patient with Tertiary Syphilis , Case Rep Gastroenterol, 16: 2022,552-556

Pang A, Zeineddine HA Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. , Cerebrovasc Dis., 43(5-6): 2017,223-230

Wood M, Rawe M, Johansson G, Pang S, Soderquist R, Patel A, Nelson S, Seibel W, Ratner N, Sanchez Y. Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cell lines. , Mol Cancer Ther. , 10(9): 2011 ,1740-1750